Here, we observed that TNBC and HER2-enriched breast cancer showed significantly higher enrichment of the STAT3 activation signature, but not the TrkA activation signature, when compared to luminal samples (Figure 1D,E). Here, ERBB2 is linked to breast carcinoma.